Clinical Trials Directory

Trials / Completed

CompletedNCT04940091

Epidural Analgesia and Maternal Fever During Labor

Association Between the Effect of Epidural Analgesia and the Development of Maternal Fever During Labor: a Multicenter, Prospective, Observational, Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,051 (actual)
Sponsor
Peking University First Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Women who receive epidural analgesia during labor are more likely to develop fever than those who do not. Maternal fever during labor can produce various harmful effects on both mothers and infants. The investigators speculate that the effect of epidural analgesia is associated with the development of maternal fever, i.e., better analgesia is associated with higher risk of maternal fever.

Detailed description

Epidural related maternal fever (ERMF) refers to the phenomenon of increased body temperature of parturient after receiving epidural analgesia during labor. Women who receive epidural labor analgesia are more likely to have fever than those who do not. In a systematic review, 20-33% of parturients receiving neuraxial analgesia developed fever during labor, compared with only 5-7% of those without neuraxial analgesia. Maternal fever can interfere with women's laboring process, decrease the sensitivity of the uterus and cervix to oxytocin, and lead to dystocia and increased surgical delivery rate. The investigators note that the rate of ERMF is lower in patients receiving lower density neuraxial blockade. The study is designed to test the hypothesis that the effect of epidural analgesia is associated with the development of maternal fever, i.e., better analgesia is associated with higher risk of maternal fever.

Conditions

Interventions

TypeNameDescription
DRUGEpidural analgesiaEpidural analgesia is performed with a mixture of local anesthetics (ropivacaine) and opioids (sufentanil).

Timeline

Start date
2021-06-10
Primary completion
2022-02-05
Completion
2022-03-21
First posted
2021-06-25
Last updated
2025-03-11

Locations

8 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04940091. Inclusion in this directory is not an endorsement.